The microRNA expression signature of small cell lung cancer: tumor suppressors of miR-27a-5p and miR-34b-3p and their targeted oncogenes

Dual tumor-suppressorsmiR-139-5pandmiR-139-3ptargetingmatrix metalloprotease 11in bladder cancer

(2016) Masaya Yonemori et al.   CANCER SCIENCE

Regulation of LOXL2 and SERPINH1 by antitumor microRNA-29a in lung cancer with idiopathic pulmonary fibrosis

(2016) Kazuto Kamikawaji et al.   JOURNAL OF HUMAN GENETICS

Analysis of APOBEC3A/3B germline deletion polymorphism in breast, cervical and oral cancers from South India and its impact on miRNA regulation

(2016) Sundaramoorthy Revathidevi et al.   TUMOR BIOLOGY

miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC

(2016) Nan Zhao et al.   Scientific Reports

MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker

(2015) Yusuke Goto et al.   BRITISH JOURNAL OF CANCER

MicroRNA-205inhibits cancer cell migration and invasion via modulation ofcentromere protein Fregulating pathways in prostate cancer

(2015) Rika Nishikawa et al.   INTERNATIONAL JOURNAL OF UROLOGY

Coordinated Targeting of the EGFR Signaling Axis by MicroRNA-27a*

(2015) Xiaoli Wu et al.   Oncotarget

Identification of tumour suppressive microRNA-451a in hypopharyngeal squamous cell carcinoma based on microRNA expression signature

(2014) I Fukumoto et al.   BRITISH JOURNAL OF CANCER

Phase III Study Comparing Amrubicin Plus Cisplatin With Irinotecan Plus Cisplatin in the Treatment of Extensive-Disease Small-Cell Lung Cancer: JCOG 0509

(2014) Miyako Satouchi et al.   JOURNAL OF CLINICAL ONCOLOGY

Downregulation of the microRNA-1/133a cluster enhances cancer cell migration and invasion in lung-squamous cell carcinoma via regulation of Coronin1C

(2014) Hiroko Mataki et al.   JOURNAL OF HUMAN GENETICS

Maternal Embryonic Leucine Zipper Kinase: Key Kinase for Stem Cell Phenotype in Glioma and Other Cancers

(2014) R. Ganguly et al.   MOLECULAR CANCER THERAPEUTICS

Topoisomerase IIα in chromosome instability and personalized cancer therapy

(2014) T Chen et al.   ONCOGENE

The MicroRNA Expression Signature of Bladder Cancer by Deep Sequencing: The Functional Significance of the miR-195/497 Cluster

(2014) Toshihiko Itesako et al.   PLoS One

Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2

(2013) M. Acunzo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Correlations of TOP2A gene aberrations and expression of topoisomerase IIα protein and TOP2A mRNA expression in primary breast cancer: A retrospective study of 86 cases using fluorescence in situ hybridization and immunohistochemistry

(2012) Hui Meng et al.   PATHOLOGY INTERNATIONAL

Resistance of colorectal cancer cells to radiation and 5-FU is associated with MELK expression

(2011) Seungho Choi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma

(2011) Yasumitsu Moriya et al.   JOURNAL OF HUMAN GENETICS

Small-cell lung cancer

(2011) Jan P van Meerbeeck et al.   LANCET

Origins and Mechanisms of miRNAs and siRNAs

(2009) Richard W. Carthew et al.   CELL

The miR-34 family in cancer and apoptosis

(2009) H Hermeking   CELL DEATH AND DIFFERENTIATION

Most mammalian mRNAs are conserved targets of microRNAs

(2008) R. C. Friedman et al.   GENOME RESEARCH

Excision Repair Cross Complementing-1 and Topoisomerase IIα Gene Expression in Small-Cell Lung Cancer Patients Treated with Platinum and Etoposide: A Retrospective Study

(2008) Paolo Ceppi et al.   Journal of Thoracic Oncology

MicroRNAs and cancer: past, present, and potential future

(2008) K. M. Nelson et al.   MOLECULAR CANCER THERAPEUTICS

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

(2008) Witold Filipowicz et al.   NATURE REVIEWS GENETICS